UPDATED — JHL Biotech Announces China Approves Phase I and Phase III Clinical Trial Application for Bevacizumab Biosimilar to Treat Cancer October 17, 2018 β 03:22
Fund News TPG-Backed Li Ning Plans $218M Share Offering To Support Growth December 18, 2014 β 12:36
